Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
Go back to Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers| BANC OF CALIFORNIA (NYSE: BANC) | Delayed: 18.35 -0.15 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.50 | 52 Week High | $23.24 | |||
| Open | $18.42 | 52 Week Low | $10.93 | |||
| Day High | $18.53 | P/E | N/A | |||
| Day Low | $18.23 | EPS | $-0.38 | |||
| Volume | 842,431 | |||||

